Who owns Vistagen Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VTGN from SEC Form 13F filings across 49 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 49 institutions disclosed 11.8M shares of Vistagen Therapeutics, Inc. worth $2.3M — about 27.4% of shares outstanding; the largest disclosed holder is Commodore Capital LP. Source: SEC Form 13F filings, parsed by EvidInvest.
49
13F holders
$2.3M
value, 2026 filers
27.4%
of shares outstanding (11.8M sh)
11
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VTGN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Commodore Capital LPNEW | 2.8M | $630,228 | 0.0% | 6.5% | new |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $355,769 | 0.0% | 3.7% | 0.0% |
| 3 | TWO SIGMA INVESTMENTS, LP | 847,992 | $191,646 | 0.0% | 2% | +80.6% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 794,579 | $178 | 0.0% | 1.8% | +34.8% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 730,500 | $165,093 | 0.0% | 1.7% | +150.8% |
| 6 | STEMPOINT CAPITAL LP | 616,749 | $17,276 | 0.0% | 1.4% | 0.0% |
| 7 | Ikarian Capital, LLC | 519,077 | $117,311 | 0.0% | 1.2% | 0.0% |
| 8 | AdvisorShares Investments LLC | 438,643 | $99,133 | 0.0% | 1% | +58.3% |
| 9 | LUMINUS MANAGEMENT LLC | 403,115 | $91,104 | 0.1% | 0.9% | +1.8% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 365,002 | $82,514 | 0.0% | 0.8% | -19.5% |
| 11 | ADAR1 Capital Management, LLC | 351,141 | $79,358 | 0.0% | 0.8% | -53.3% |
| 12 | BlackRock, Inc. | 345,432 | $78,068 | 0.0% | 0.8% | -23.0% |
| 13 | GROUP ONE TRADING LLC | 304,385 | $68,791 | 0.0% | 0.7% | +1431.5% |
| 14 | Verdad Advisers, LP | 293,343 | $66,296 | 0.1% | 0.7% | +58.6% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 217,700 | $49,200 | 0.0% | 0.5% | 0.0% |
| 16 | JANE STREET GROUP, LLC | 164,827 | $37,251 | 0.0% | 0.4% | -39.6% |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | 134,571 | $30,413 | 0.0% | 0.3% | 0.0% |
| 18 | STATE STREET CORP | 121,114 | $27,372 | 0.0% | 0.3% | 0.0% |
| 19 | XTX Topco Ltd | 118,380 | $26,754 | 0.0% | 0.3% | -22.6% |
| 20 | NORTHERN TRUST CORP | 80,823 | $18,266 | 0.0% | 0.2% | +11.2% |
| 21 | CITADEL ADVISORS LLCNEW | 68,839 | $15,558 | 0.0% | 0.2% | new |
| 22 | Virtu Financial LLCNEW | 66,021 | $15 | 0.0% | 0.2% | new |
| 23 | UBS Group AG | 57,830 | $13,070 | 0.0% | 0.1% | -26.6% |
| 24 | GSA CAPITAL PARTNERS LLP | 54,584 | $12 | 0.0% | 0.1% | +9.5% |
| 25 | OSAIC HOLDINGS, INC. | 43,888 | $10,076 | 0.0% | 0.1% | +961.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.